ACTION-Grid

ACTION-Grid is a Specific International Cooperation Project on healthcare information systems based on Grid capabilities and Biomedical Informatics (BMI) between Latin America, the Western Balkans and the European Union (EU). Members of the consortium have published pioneering scientific papers in Grid and BMI. They participated in the BIOINFOMED and SYMBIOMATICS studies that contributed decisively to the last two FPs of the EC.

ACTION-Grid will act as a multiplier of previous outcomes in Grid and BMI. ACTION-Grid will disseminate these outcomes in Latin America, the Western Balkans and North Africa.

Subobjectives:

  • To survey Grid-based and BMI initiatives in Europe, Latin America, the Western Balkans and North Africa. These results will be combined with data from an inventory of Grid/Nano/BMI methods and services-, developed by the consortium.
  • Based on previous EC-based projects, ACTION-Grid will foster training and mobility in Grid and BMI.
  • To develop a White Paper, in collaboration with a panel of recognized experts. This document will be delivered to the EC to establish a future agenda covering the Grid/Nano/Bio/Medical Informatics areas and develop new plans in Latin America, the Western Balkans and North Africa.
  • To disseminate ACTION-Grid, by means of:
    • An international symposium on Grid and BMI. This conference will be carried out in Europe, with two satellite conferences
    • Scientific publications,
    • Dissemination strategies, such as a Website, Newsletters, Press releases, etc.

To expand previous initiatives to create a common health information infrastructure in Europe, and extending it to other regions. It will enhance cooperation between research centres, universities, hospitals, SMEs, public entities, and others. ACTION-Grid will expand the impact of EC achievements in Grid and BMI to researchers, educators, and health practitioners' world-wide.

For further information, please visit:
http://www.action-grid.eu

Project co-ordinator:
Universidad Politécnica de Madrid

Partners:

  • Universidad de Talca
  • Sveučilište u Zagrebu Medicinski fakultet
  • Foundation for Research and Technology - Hellas
  • Instituto de Salud Carlos III
  • HealthGrid
  • Sociedad Italiana de Beneficencia en Buenos Aires

Timetable: from 06/2008 – to 11/2009

Total cost: € 1.118.402

EC funding: € 999.077

Programme Acronym: FP7-ICT

Subprogramme Area: Virtual physiological human

Contract type: Coordination and support actions

Related news article:

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Big Data Approach Shown to be Effective …

Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments. The...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...